Members access personalized protocols, expert-reviewed handling guides, and real-time support for situations exactly like this one
As demonstrated in multiple approved TransCon products, carefully engineered PEG carrier systems can help enable weekly or extended dosing while preserving the activity of the parent drug
$100 consultation fee goes towards service
Brello positions itself alongside other compounded GLP-1 providers in a market that expanded significantly after semaglutide became one of the most sought-after medications in recent memory
Fast 24-hour approval and 2-day shipping Available in all 50 states Insurance accepted for branded GLP-1s Clinician profiles visible in patient portal Unlimited messaging with provider and coach Not LegitScript certified Hidden pricing with confusing disclaimers Pushy countdown timers and sales tactics Pharmacy partners not disclosed BBB D- rating with pattern of complaints BEFORE WE DIG IN How Zealthy works + is it right for you
Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors currently in Phase 3 trials with no global regulatory approval